Anaphylaxis and anesthesia: controversies and new insights.
Dewachter
Pascale
P
Service d'Anesthésie-Réanimation & Service d'Aide Médicale Urgente (SAMU) de Paris, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Université Paris-Descartes, France. pascale.dewachter@nck.aphp.fr
Mouton-Faivre
Claudie
C
Emala
Charles W
CW
D000707:Anaphylaxis / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D000732:Androstanols / Q000009:adverse effects; D000758:Anesthesia / Q000009:adverse effects*; D000779:Anesthetics, Local / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001127:Arginine Vasopressin / Q000502:physiology; D004342:Drug Hypersensitivity / Q000209:etiology; D006706:Homeostasis; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D020315:Latex Hypersensitivity / Q000150:complications; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects; D012307:Risk Factors; D000077123:Rocuronium; D012882:Skin Tests
D000732:Androstanols; D000779:Anesthetics, Local; D000900:Anti-Bacterial Agents; D009466:Neuromuscular Blocking Agents; D001127:Arginine Vasopressin; D007073:Immunoglobulin E; D000077123:Rocuronium